MedPath

Observational Study to Assess Safety and Utility Pattern of Topical Steroids

Completed
Conditions
Skin Diseases
Registration Number
NCT02377557
Lead Sponsor
Hanyang University
Brief Summary

To assess incidence of adverse drug reactions and use pattern of topical steroids among patients who are prescribed or purchase over the counter (OTC) topical steroids for skin conditions in Korea

Detailed Description

* Active collection of safety data, systemic and local adverse events.

* In addition to spontaneous adverse event reports, patients will be asked on occurrence of adverse events upon use of topical steroids at 1 month, 2 month, and 6 month after study enrollment by e-mail or phone call

* Causality of adverse events will be assessed by independent two professionals

* Document the utility pattern of topical steroid, misuse (inappropriate indication) or overuse (in terms of application frequency or treatment duration)

* Collection of information related with adverse event management

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1175
Inclusion Criteria
  • All patients or guardian of child purchased topical steroids in Korea
  • Informed consent to participate
  • Willing to follow and abide by the protocol
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of adverse drug reaction upon use of topical steroid4 week after time of enrollment
Secondary Outcome Measures
NameTimeMethod
Rate of adverse drug reaction upon use of topical steroid6 month after time of enrollment
Rate of misuse and overuse of topical steroids6 month after time of enrollment
Impact of covariates on incidence of adverse drug reaction6 month after time of enrollment
Rate of adverse drug reaction by potency, route of purchase (prescription/self diagnosed), drug classification (prescription only/over the counter)1 month after time of enrollment

Trial Locations

Locations (1)

College of Pharmacy, Hanyang University

🇰🇷

Gyeonggi, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath